New York City Council     Members

This bill would require the New York City Police Department (NYPD) to report quarterly – to the Mayor, City Council, and the Department of Health and Mental Hygiene – on the number of opioid antagonists the department has available, the number of officers trained to administer opioid antagonists, and the number of opioid overdose reversal drugs administered by NYPD Officers.

  • Enacted

History

Mayor
Signed Into Law by Mayor
Mayor
Hearing Held by Mayor
City Council
Sent to Mayor by Council
City Council
Pass
Approved by Council
Committee on Mental Health, Disabilities and Addiction
Hearing Held by Committee
Committee on Mental Health, Disabilities and Addiction
Amendment Proposed by Comm
Committee on Mental Health, Disabilities and Addiction
Amended by Committee
Committee on Mental Health, Disabilities and Addiction
Pass
Approved by Committee
City Council
Referred to Comm by Council
City Council
Introduced by Council
Committee on General Welfare
P-C Item Laid Over by Comm
Committee on General Welfare
Hearing on P-C Item by Comm
Committee on Mental Health, Disabilities and Addiction
P-C Item Laid Over by Comm
Committee on Mental Health, Disabilities and Addiction
Hearing on P-C Item by Comm

Int. No. 717-A

 

By Council Members Williams, Holden, Ampry-Samuel, Levin, Kallos and Rivera

 

A Local Law to amend the administrative code of the city of New York, in relation to requiring the police department to submit to the council reports relating to opioid antagonists

 

Be it enacted by the Council as follows:

 

Section 1. Chapter one of title 14 of the administrative code of the city of New York is amended to add a new section 14-176 to read as follows:

§ 14-176 Opioid antagonist report. a. For the purpose of this section, the following terms have the following meanings:

Officer. The term “officer” has the same meaning as defined under section 14-174.

Opioid antagonist. The term “opioid antagonist” means naloxone, narcan or other medication approved by the New York state department of health and the federal food and drug administration that, when administered, negates or neutralizes in whole or in part the pharmacological effects of an opioid in the human body.

b. Beginning with the calendar quarter starting on January 1, 2019, the commissioner shall submit to the speaker of the council and the department of health and mental hygiene, within 25 days of the end of each quarter and post to the department’s website five days thereafter, a report relating to opioid antagonists, which shall include:

1. The number of opioid antagonists the department has available for use in reversing the effects of a heroin or opioid overdose, disaggregated by patrol borough;

2. The number of officers trained in the department to administer opioid antagonists to overdose victims, disaggregated by patrol borough; and

3. The number of times in the quarter that an officer administered an opioid antagonists to an overdose victim, disaggregated by patrol borough and by the way in which the opioid antagonist was administered to such overdose victim, such as by syringe injection or nasal atomizer. Such number shall be expressed in both absolute terms and as a percentage of all administrations.

c. The report created pursuant to this section shall be provided within 30 days of the end of the quarter to which the report corresponds. Where necessary, the department may use preliminary data to prepare the required report.  If preliminary data is used, the department shall include an acknowledgment that such preliminary data is non-final and subject to change.

§ 2.  This local law takes effect 60 days after it becomes law.

 

CJG/JDK/SSY

LS #1911/Int. 548/2014

LS # 400

5/30/18 8:00 pm